METformin in DIastolic Dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design : MET-DIME trial. (Q48086135)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

METformin in DIastolic Dysfunction of MEtabolic syndrome (MET-DIME) trial: rationale and study design : MET-DIME trial (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

1 reference

1 reference

1 reference

Ricardo Fontes-Carvalho

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Adelino F Leite-Moreira

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Ricardo Ladeiras-Lopes

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Nuno Bettencourt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Francisco Sampaio

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Vasco Gama

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

1 April 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

Cardiovascular Drugs and Therapy

7 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

191-196

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

cites work

The metabolic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Impact of metabolic syndrome definitions on prevalence estimates: a study in a Portuguese community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Metabolic syndrome as a risk factor for neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Pre-diabetes, metabolic syndrome, and cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Assessment of nonischemic myocardial fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Diastolic dysfunction in exercise and its role for exercise capacity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Subclinical Myocardial Dysfunction in Metabolic Syndrome Patients without Hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Heart failure with preserved ejection fraction: fighting misconceptions for a new approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Trends in patients hospitalized with heart failure and preserved left ventricular ejection fraction: prevalence, therapies, and outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Acute neurohumoral modulation of diastolic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Cardiac fibrosis and vascular remodeling are attenuated by metformin in obese rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Metformin prevents the development of chronic heart failure in the SHHF rat model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Metformin attenuates ventricular hypertrophy by activating the AMP-activated protein kinase-endothelial nitric oxide synthase pathway in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

Recommendations for the evaluation of left ventricular diastolic function by echocardiography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-014-6512-2

10.1007/S10557-014-6512-2

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24515256%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference